Metraipolis › archive › dc_cba72a7fcf93

The efficacy and safety of remimazolam for the management of emergence agitation: a randomized, double-blind, placebo-controlled study — Europe PMC PMID:40904354

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40904354
DOI
10.3389/fmed.2025.1612779
License (as archived)
solo-consultazione
Archived
2026-11-10T12:03:52.699Z
SHA-256 of the archived text
f0f2396885662b4490262f83cfea04730fb022ca07cf77cd5e31581fb66c5abf
Stable URL of this page
https://metraipolis.com/documento/dc_cba72a7fcf93

How to cite

The efficacy and safety of remimazolam for the management of emergence agitation: a randomized, double-blind, placebo-controlled study — Europe PMC PMID:40904354 — Europe PMC (en), https://europepmc.org/article/MED/40904354 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cba72a7fcf93 (Metraipolis archive dc_cba72a7fcf93, sha256 f0f2396885662b4490262f83cfea04730fb022ca07cf77cd5e31581fb66c5abf)
BibTeX
@misc{dccba72a7fcf93,
  title = {The efficacy and safety of remimazolam for the management of emergence agitation: a randomized, double-blind, placebo-controlled study — Europe PMC PMID:40904354},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40904354},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cba72a7fcf93; sha256 f0f2396885662b4490262f83cfea04730fb022ca07cf77cd5e31581fb66c5abf},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40904354. Agents can read the archived copy with the MCP tool read_document.